Summary of a workshop on potency and dosage of von Willebrand factor concentrates
Haemophilia
.
1998:4 Suppl 3:1-6.
doi: 10.1046/j.1365-2516.1998.0040s3001.x.
Authors
A C Chang
1
,
M E Rick
,
L Ross Pierce
,
M J Weinstein
Affiliation
1
Division of Hematology, Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), Bethesda, MD 20892, USA.
PMID:
10028311
DOI:
10.1046/j.1365-2516.1998.0040s3001.x
No abstract available
Publication types
Congress
MeSH terms
Clinical Trials as Topic / standards
Humans
von Willebrand Diseases / drug therapy*
von Willebrand Factor / administration & dosage*
von Willebrand Factor / standards
Substances
von Willebrand Factor